RecruitingNCT05240651

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

Sponsor

NYU Langone Health

Enrollment

50 participants

Start Date

Aug 30, 2022

Study Type

OBSERVATIONAL

Conditions

Acute Decompensated Heart Failure

Summary

This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management System (Baxter Medical, Deerfield, IL) in determining volume status in patients with acute decompensated heart failure requiring intravenous diuretic therapy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study measures changes in how much blood the heart pumps per beat after patients with acute decompensated heart failure receive IV diuretics (water pills given through a vein to remove excess fluid). Researchers want to better understand how fluid removal affects heart function. **You may be eligible if...** - You have been admitted to a cardiac intensive care or step-down unit with worsening heart failure requiring IV diuretics - You are expected to need IV diuretics for more than 24 hours - You are 18 or older and able to provide consent **You may NOT be eligible if...** - You have end-stage kidney disease requiring dialysis - You cannot physically perform a passive leg-raise test (e.g., due to spinal injury, amputation, or a heart pump device) - You are pregnant, postpartum, or currently incarcerated Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.